Report Feature
Clinical Trial Supply Market Trends and Forecast
The future of the clinical trial supply market looks promising with opportunities in the pharmaceutical & biotechnology companies, contract research organisations, and medical device companies segment. The global clinical trial supply market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of 7.7% from 2023 to 2028. The major drivers for this market are increasing R&D expenditure by the pharmaceutical and biotechnology companies, growing prevalence of diseases, and the globalization of clinical trials.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Clinical Trial Supply Market by Segment
The study includes trends and forecast for the global clinical trial supply market by service, type, therapeutic area, end use industry, and region, as follows:
Clinical Trial Supply Market by Service [Value ($B) Shipment Analysis from 2017 to 2028]:
- Logistics & Distribution
- Storage & Retention
- Packaging, Labeling, and Blinding
- Manufacturing
- Comparator Sourcing
Clinical Trial Supply Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Small-Molecules
- Biologic Drugs
- Medical Devices
Clinical Trial Supply Market by Therapeutic Area [Value ($B) Shipment Analysis from 2017 to 2028]:
- Oncology
- CNS and Mental Disorders
- Cardiovascular Diseases
- Digestive Disorders
- Infectious Diseases
- Metabolic Disorders
- Immunology
- Blood Disorders
Clinical Trial Supply Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
- Pharmaceutical & Biotechnology Companies
- Contract Research Organisations (CROs)
- Medical Device Companies
Clinical Trial Supply Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Clinical Trial Supply Companies
Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, clinical trial supply companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the clinical trial supply companies profiled in this report include-
Clinical Trial Supply Market Insights
- Lucintel forecasts that oncology are expected to remain the largest segment over the forecast period as pharmaceutical and biotechnology companies are focusing on bringing innovative cancer drugs into the market.
- Within this market, pharmaceutical and biotechnology is expected to remain the largest segment over the forecast period due to increasing in number of clinical trails being conducted pharmaceutical and biotechnology companies to develop new drugs and treatment that drives the market.
- APAC is expected to witness the highest growth over the forecast period due to growing demand of new and effective drugs and the region is large with diverse population that provides a large pool of potential clinical trial participant for drug development companies.
Features of the Clinical Trial Supply Market
- Market Size Estimates: Clinical trial supply market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Clinical trial supply market size by various segments, such as service, type, therapeutic area, end use industry, and region.
- Regional Analysis: Clinical trial supply market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different service, type, therapeutic area, end use industry, and region for the clinical trial supply market.
- Strategic Analysis: This includes M&A, new type development, and competitive landscape for the clinical trial supply market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the clinical trial supply market size?
Answer: The global clinical trial supply market is expected to reach an estimated $4.0 billion by 2028.
Q2. What is the growth forecast for clinical trial supply market?
Answer: The global clinical trial supply market is expected to grow with a CAGR of 7.7% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the clinical trial supply market?
Answer: The major drivers for this market are increasing R&D expenditure by the pharmaceutical and biotechnology companies, growing prevalence of diseases, and the globalization of clinical trials.
Q4. What are the major segments for clinical trial supply market?
Answer: The future of the clinical trial supply market looks promising with opportunities in the pharmaceutical & biotechnology companies, contract research organisations, and medical device companies.
Q5. Who are the key clinical trial supply companies?
Answer: Some of the key clinical trial supply companies are as follows:
Answer: The global clinical trial supply market is expected to reach an estimated $4.0 billion by 2028.
Q2. What is the growth forecast for clinical trial supply market?
Answer: The global clinical trial supply market is expected to grow with a CAGR of 7.7% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the clinical trial supply market?
Answer: The major drivers for this market are increasing R&D expenditure by the pharmaceutical and biotechnology companies, growing prevalence of diseases, and the globalization of clinical trials.
Q4. What are the major segments for clinical trial supply market?
Answer: The future of the clinical trial supply market looks promising with opportunities in the pharmaceutical & biotechnology companies, contract research organisations, and medical device companies.
Q5. Who are the key clinical trial supply companies?
Answer: Some of the key clinical trial supply companies are as follows:
- Thermo Fisher Scientific
- Marken
- Catalent
- Eurofins Scientific
- PRA Health Sciences
Q6. Which clinical trial supply segment will be the largest in future?
Answer: Lucintel forecasts that oncology are expected to remain the largest segment over the forecast period as pharmaceutical and biotechnology companies are focusing on bringing innovative cancer drugs into the market.
Q7. In clinical trial supply market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to growing demand of new and effective drugs and the region is large with diverse population that provides a large pool of potential clinical trial participant for drug development companies.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Answer: Lucintel forecasts that oncology are expected to remain the largest segment over the forecast period as pharmaceutical and biotechnology companies are focusing on bringing innovative cancer drugs into the market.
Q7. In clinical trial supply market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period due to growing demand of new and effective drugs and the region is large with diverse population that provides a large pool of potential clinical trial participant for drug development companies.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
